Pharma & Healthcare
Global Somatostatin Market Research Report 2025
- May 05, 25
- ID: 228814
- Pages: 99
- Figures: 105
- Views: 29
The global market for Somatostatin was valued at US$ 417 million in the year 2024 and is projected to reach a revised size of US$ 879 million by 2031, growing at a CAGR of 11.4% during the forecast period.
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, followed by Europe and India.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Somatostatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Somatostatin.
The Somatostatin market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Somatostatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Somatostatin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
Segment by Type
0.25mg/pcs
0.75mg/pcs
3mg/pcs
Segment by Application
Hormonal Disorder
Oncology
Metabolic Disorder
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Somatostatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Somatostatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.
China is the largest market, followed by Europe and India.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Somatostatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Somatostatin.
The Somatostatin market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Somatostatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Somatostatin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
Segment by Type
0.25mg/pcs
0.75mg/pcs
3mg/pcs
Segment by Application
Hormonal Disorder
Oncology
Metabolic Disorder
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Somatostatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Somatostatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Somatostatin Market Overview
1.1 Product Definition
1.2 Somatostatin by Type
1.2.1 Global Somatostatin Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.25mg/pcs
1.2.3 0.75mg/pcs
1.2.4 3mg/pcs
1.3 Somatostatin by Application
1.3.1 Global Somatostatin Market Value by Application (2024 VS 2031)
1.3.2 Hormonal Disorder
1.3.3 Oncology
1.3.4 Metabolic Disorder
1.3.5 Others
1.4 Global Somatostatin Market Size Estimates and Forecasts
1.4.1 Global Somatostatin Revenue 2020-2031
1.4.2 Global Somatostatin Sales 2020-2031
1.4.3 Global Somatostatin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Somatostatin Market Competition by Manufacturers
2.1 Global Somatostatin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Somatostatin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Somatostatin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Somatostatin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Somatostatin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Somatostatin, Product Type & Application
2.7 Global Key Manufacturers of Somatostatin, Date of Enter into This Industry
2.8 Global Somatostatin Market Competitive Situation and Trends
2.8.1 Global Somatostatin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Somatostatin Players Market Share by Revenue
2.8.3 Global Somatostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Somatostatin Market Scenario by Region
3.1 Global Somatostatin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Somatostatin Sales by Region: 2020-2031
3.2.1 Global Somatostatin Sales by Region: 2020-2025
3.2.2 Global Somatostatin Sales by Region: 2026-2031
3.3 Global Somatostatin Revenue by Region: 2020-2031
3.3.1 Global Somatostatin Revenue by Region: 2020-2025
3.3.2 Global Somatostatin Revenue by Region: 2026-2031
3.4 North America Somatostatin Market Facts & Figures by Country
3.4.1 North America Somatostatin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Somatostatin Sales by Country (2020-2031)
3.4.3 North America Somatostatin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Somatostatin Market Facts & Figures by Country
3.5.1 Europe Somatostatin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Somatostatin Sales by Country (2020-2031)
3.5.3 Europe Somatostatin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Somatostatin Market Facts & Figures by Region
3.6.1 Asia Pacific Somatostatin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Somatostatin Sales by Region (2020-2031)
3.6.3 Asia Pacific Somatostatin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Somatostatin Market Facts & Figures by Country
3.7.1 Latin America Somatostatin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Somatostatin Sales by Country (2020-2031)
3.7.3 Latin America Somatostatin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Somatostatin Market Facts & Figures by Country
3.8.1 Middle East and Africa Somatostatin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Somatostatin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Somatostatin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Somatostatin Sales by Type (2020-2031)
4.1.1 Global Somatostatin Sales by Type (2020-2025)
4.1.2 Global Somatostatin Sales by Type (2026-2031)
4.1.3 Global Somatostatin Sales Market Share by Type (2020-2031)
4.2 Global Somatostatin Revenue by Type (2020-2031)
4.2.1 Global Somatostatin Revenue by Type (2020-2025)
4.2.2 Global Somatostatin Revenue by Type (2026-2031)
4.2.3 Global Somatostatin Revenue Market Share by Type (2020-2031)
4.3 Global Somatostatin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Somatostatin Sales by Application (2020-2031)
5.1.1 Global Somatostatin Sales by Application (2020-2025)
5.1.2 Global Somatostatin Sales by Application (2026-2031)
5.1.3 Global Somatostatin Sales Market Share by Application (2020-2031)
5.2 Global Somatostatin Revenue by Application (2020-2031)
5.2.1 Global Somatostatin Revenue by Application (2020-2025)
5.2.2 Global Somatostatin Revenue by Application (2026-2031)
5.2.3 Global Somatostatin Revenue Market Share by Application (2020-2031)
5.3 Global Somatostatin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck (Schweiz) AG
6.1.1 Merck (Schweiz) AG Company Information
6.1.2 Merck (Schweiz) AG Description and Business Overview
6.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck (Schweiz) AG Somatostatin Product Portfolio
6.1.5 Merck (Schweiz) AG Recent Developments/Updates
6.2 SANOFI-AVENTIS FRANCE
6.2.1 SANOFI-AVENTIS FRANCE Company Information
6.2.2 SANOFI-AVENTIS FRANCE Description and Business Overview
6.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 SANOFI-AVENTIS FRANCE Somatostatin Product Portfolio
6.2.5 SANOFI-AVENTIS FRANCE Recent Developments/Updates
6.3 Lyomark Pharma GmbH
6.3.1 Lyomark Pharma GmbH Company Information
6.3.2 Lyomark Pharma GmbH Description and Business Overview
6.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Lyomark Pharma GmbH Somatostatin Product Portfolio
6.3.5 Lyomark Pharma GmbH Recent Developments/Updates
6.4 ALFA WASSERMANN S.p.A.
6.4.1 ALFA WASSERMANN S.p.A. Company Information
6.4.2 ALFA WASSERMANN S.p.A. Description and Business Overview
6.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ALFA WASSERMANN S.p.A. Somatostatin Product Portfolio
6.4.5 ALFA WASSERMANN S.p.A. Recent Developments/Updates
6.5 Polypeptide Laboratories, Inc
6.5.1 Polypeptide Laboratories, Inc Company Information
6.5.2 Polypeptide Laboratories, Inc Description and Business Overview
6.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Polypeptide Laboratories, Inc Somatostatin Product Portfolio
6.5.5 Polypeptide Laboratories, Inc Recent Developments/Updates
6.6 SAMARTH
6.6.1 SAMARTH Company Information
6.6.2 SAMARTH Description and Business Overview
6.6.3 SAMARTH Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SAMARTH Somatostatin Product Portfolio
6.6.5 SAMARTH Recent Developments/Updates
6.7 UBPL
6.7.1 UBPL Company Information
6.7.2 UBPL Description and Business Overview
6.7.3 UBPL Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 UBPL Somatostatin Product Portfolio
6.7.5 UBPL Recent Developments/Updates
6.8 HYBIO
6.8.1 HYBIO Company Information
6.8.2 HYBIO Description and Business Overview
6.8.3 HYBIO Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 HYBIO Somatostatin Product Portfolio
6.8.5 HYBIO Recent Developments/Updates
6.9 TianTaiShan
6.9.1 TianTaiShan Company Information
6.9.2 TianTaiShan Description and Business Overview
6.9.3 TianTaiShan Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 TianTaiShan Somatostatin Product Portfolio
6.9.5 TianTaiShan Recent Developments/Updates
6.10 Yangtze River
6.10.1 Yangtze River Company Information
6.10.2 Yangtze River Description and Business Overview
6.10.3 Yangtze River Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Yangtze River Somatostatin Product Portfolio
6.10.5 Yangtze River Recent Developments/Updates
6.11 Siyao
6.11.1 Siyao Company Information
6.11.2 Siyao Description and Business Overview
6.11.3 Siyao Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Siyao Somatostatin Product Portfolio
6.11.5 Siyao Recent Developments/Updates
6.12 Shuangcheng
6.12.1 Shuangcheng Company Information
6.12.2 Shuangcheng Description and Business Overview
6.12.3 Shuangcheng Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shuangcheng Somatostatin Product Portfolio
6.12.5 Shuangcheng Recent Developments/Updates
6.13 Hainan Zhonghe
6.13.1 Hainan Zhonghe Company Information
6.13.2 Hainan Zhonghe Description and Business Overview
6.13.3 Hainan Zhonghe Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hainan Zhonghe Somatostatin Product Portfolio
6.13.5 Hainan Zhonghe Recent Developments/Updates
6.14 SL PHARM
6.14.1 SL PHARM Company Information
6.14.2 SL PHARM Description and Business Overview
6.14.3 SL PHARM Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 SL PHARM Somatostatin Product Portfolio
6.14.5 SL PHARM Recent Developments/Updates
6.15 Wuhan Hualong
6.15.1 Wuhan Hualong Company Information
6.15.2 Wuhan Hualong Description and Business Overview
6.15.3 Wuhan Hualong Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Wuhan Hualong Somatostatin Product Portfolio
6.15.5 Wuhan Hualong Recent Developments/Updates
6.16 Qingdao Guoda
6.16.1 Qingdao Guoda Company Information
6.16.2 Qingdao Guoda Description and Business Overview
6.16.3 Qingdao Guoda Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Qingdao Guoda Somatostatin Product Portfolio
6.16.5 Qingdao Guoda Recent Developments/Updates
6.17 Chengdu Shengnuo
6.17.1 Chengdu Shengnuo Company Information
6.17.2 Chengdu Shengnuo Description and Business Overview
6.17.3 Chengdu Shengnuo Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Chengdu Shengnuo Somatostatin Product Portfolio
6.17.5 Chengdu Shengnuo Recent Developments/Updates
6.18 Longjin
6.18.1 Longjin Company Information
6.18.2 Longjin Description and Business Overview
6.18.3 Longjin Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Longjin Somatostatin Product Portfolio
6.18.5 Longjin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Somatostatin Industry Chain Analysis
7.2 Somatostatin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Somatostatin Production Mode & Process Analysis
7.4 Somatostatin Sales and Marketing
7.4.1 Somatostatin Sales Channels
7.4.2 Somatostatin Distributors
7.5 Somatostatin Customer Analysis
8 Somatostatin Market Dynamics
8.1 Somatostatin Industry Trends
8.2 Somatostatin Market Drivers
8.3 Somatostatin Market Challenges
8.4 Somatostatin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Somatostatin by Type
1.2.1 Global Somatostatin Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.25mg/pcs
1.2.3 0.75mg/pcs
1.2.4 3mg/pcs
1.3 Somatostatin by Application
1.3.1 Global Somatostatin Market Value by Application (2024 VS 2031)
1.3.2 Hormonal Disorder
1.3.3 Oncology
1.3.4 Metabolic Disorder
1.3.5 Others
1.4 Global Somatostatin Market Size Estimates and Forecasts
1.4.1 Global Somatostatin Revenue 2020-2031
1.4.2 Global Somatostatin Sales 2020-2031
1.4.3 Global Somatostatin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Somatostatin Market Competition by Manufacturers
2.1 Global Somatostatin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Somatostatin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Somatostatin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Somatostatin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Somatostatin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Somatostatin, Product Type & Application
2.7 Global Key Manufacturers of Somatostatin, Date of Enter into This Industry
2.8 Global Somatostatin Market Competitive Situation and Trends
2.8.1 Global Somatostatin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Somatostatin Players Market Share by Revenue
2.8.3 Global Somatostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Somatostatin Market Scenario by Region
3.1 Global Somatostatin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Somatostatin Sales by Region: 2020-2031
3.2.1 Global Somatostatin Sales by Region: 2020-2025
3.2.2 Global Somatostatin Sales by Region: 2026-2031
3.3 Global Somatostatin Revenue by Region: 2020-2031
3.3.1 Global Somatostatin Revenue by Region: 2020-2025
3.3.2 Global Somatostatin Revenue by Region: 2026-2031
3.4 North America Somatostatin Market Facts & Figures by Country
3.4.1 North America Somatostatin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Somatostatin Sales by Country (2020-2031)
3.4.3 North America Somatostatin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Somatostatin Market Facts & Figures by Country
3.5.1 Europe Somatostatin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Somatostatin Sales by Country (2020-2031)
3.5.3 Europe Somatostatin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Somatostatin Market Facts & Figures by Region
3.6.1 Asia Pacific Somatostatin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Somatostatin Sales by Region (2020-2031)
3.6.3 Asia Pacific Somatostatin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Somatostatin Market Facts & Figures by Country
3.7.1 Latin America Somatostatin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Somatostatin Sales by Country (2020-2031)
3.7.3 Latin America Somatostatin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Somatostatin Market Facts & Figures by Country
3.8.1 Middle East and Africa Somatostatin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Somatostatin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Somatostatin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Somatostatin Sales by Type (2020-2031)
4.1.1 Global Somatostatin Sales by Type (2020-2025)
4.1.2 Global Somatostatin Sales by Type (2026-2031)
4.1.3 Global Somatostatin Sales Market Share by Type (2020-2031)
4.2 Global Somatostatin Revenue by Type (2020-2031)
4.2.1 Global Somatostatin Revenue by Type (2020-2025)
4.2.2 Global Somatostatin Revenue by Type (2026-2031)
4.2.3 Global Somatostatin Revenue Market Share by Type (2020-2031)
4.3 Global Somatostatin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Somatostatin Sales by Application (2020-2031)
5.1.1 Global Somatostatin Sales by Application (2020-2025)
5.1.2 Global Somatostatin Sales by Application (2026-2031)
5.1.3 Global Somatostatin Sales Market Share by Application (2020-2031)
5.2 Global Somatostatin Revenue by Application (2020-2031)
5.2.1 Global Somatostatin Revenue by Application (2020-2025)
5.2.2 Global Somatostatin Revenue by Application (2026-2031)
5.2.3 Global Somatostatin Revenue Market Share by Application (2020-2031)
5.3 Global Somatostatin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck (Schweiz) AG
6.1.1 Merck (Schweiz) AG Company Information
6.1.2 Merck (Schweiz) AG Description and Business Overview
6.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck (Schweiz) AG Somatostatin Product Portfolio
6.1.5 Merck (Schweiz) AG Recent Developments/Updates
6.2 SANOFI-AVENTIS FRANCE
6.2.1 SANOFI-AVENTIS FRANCE Company Information
6.2.2 SANOFI-AVENTIS FRANCE Description and Business Overview
6.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 SANOFI-AVENTIS FRANCE Somatostatin Product Portfolio
6.2.5 SANOFI-AVENTIS FRANCE Recent Developments/Updates
6.3 Lyomark Pharma GmbH
6.3.1 Lyomark Pharma GmbH Company Information
6.3.2 Lyomark Pharma GmbH Description and Business Overview
6.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Lyomark Pharma GmbH Somatostatin Product Portfolio
6.3.5 Lyomark Pharma GmbH Recent Developments/Updates
6.4 ALFA WASSERMANN S.p.A.
6.4.1 ALFA WASSERMANN S.p.A. Company Information
6.4.2 ALFA WASSERMANN S.p.A. Description and Business Overview
6.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ALFA WASSERMANN S.p.A. Somatostatin Product Portfolio
6.4.5 ALFA WASSERMANN S.p.A. Recent Developments/Updates
6.5 Polypeptide Laboratories, Inc
6.5.1 Polypeptide Laboratories, Inc Company Information
6.5.2 Polypeptide Laboratories, Inc Description and Business Overview
6.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Polypeptide Laboratories, Inc Somatostatin Product Portfolio
6.5.5 Polypeptide Laboratories, Inc Recent Developments/Updates
6.6 SAMARTH
6.6.1 SAMARTH Company Information
6.6.2 SAMARTH Description and Business Overview
6.6.3 SAMARTH Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SAMARTH Somatostatin Product Portfolio
6.6.5 SAMARTH Recent Developments/Updates
6.7 UBPL
6.7.1 UBPL Company Information
6.7.2 UBPL Description and Business Overview
6.7.3 UBPL Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 UBPL Somatostatin Product Portfolio
6.7.5 UBPL Recent Developments/Updates
6.8 HYBIO
6.8.1 HYBIO Company Information
6.8.2 HYBIO Description and Business Overview
6.8.3 HYBIO Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 HYBIO Somatostatin Product Portfolio
6.8.5 HYBIO Recent Developments/Updates
6.9 TianTaiShan
6.9.1 TianTaiShan Company Information
6.9.2 TianTaiShan Description and Business Overview
6.9.3 TianTaiShan Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 TianTaiShan Somatostatin Product Portfolio
6.9.5 TianTaiShan Recent Developments/Updates
6.10 Yangtze River
6.10.1 Yangtze River Company Information
6.10.2 Yangtze River Description and Business Overview
6.10.3 Yangtze River Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Yangtze River Somatostatin Product Portfolio
6.10.5 Yangtze River Recent Developments/Updates
6.11 Siyao
6.11.1 Siyao Company Information
6.11.2 Siyao Description and Business Overview
6.11.3 Siyao Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Siyao Somatostatin Product Portfolio
6.11.5 Siyao Recent Developments/Updates
6.12 Shuangcheng
6.12.1 Shuangcheng Company Information
6.12.2 Shuangcheng Description and Business Overview
6.12.3 Shuangcheng Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shuangcheng Somatostatin Product Portfolio
6.12.5 Shuangcheng Recent Developments/Updates
6.13 Hainan Zhonghe
6.13.1 Hainan Zhonghe Company Information
6.13.2 Hainan Zhonghe Description and Business Overview
6.13.3 Hainan Zhonghe Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hainan Zhonghe Somatostatin Product Portfolio
6.13.5 Hainan Zhonghe Recent Developments/Updates
6.14 SL PHARM
6.14.1 SL PHARM Company Information
6.14.2 SL PHARM Description and Business Overview
6.14.3 SL PHARM Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 SL PHARM Somatostatin Product Portfolio
6.14.5 SL PHARM Recent Developments/Updates
6.15 Wuhan Hualong
6.15.1 Wuhan Hualong Company Information
6.15.2 Wuhan Hualong Description and Business Overview
6.15.3 Wuhan Hualong Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Wuhan Hualong Somatostatin Product Portfolio
6.15.5 Wuhan Hualong Recent Developments/Updates
6.16 Qingdao Guoda
6.16.1 Qingdao Guoda Company Information
6.16.2 Qingdao Guoda Description and Business Overview
6.16.3 Qingdao Guoda Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Qingdao Guoda Somatostatin Product Portfolio
6.16.5 Qingdao Guoda Recent Developments/Updates
6.17 Chengdu Shengnuo
6.17.1 Chengdu Shengnuo Company Information
6.17.2 Chengdu Shengnuo Description and Business Overview
6.17.3 Chengdu Shengnuo Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Chengdu Shengnuo Somatostatin Product Portfolio
6.17.5 Chengdu Shengnuo Recent Developments/Updates
6.18 Longjin
6.18.1 Longjin Company Information
6.18.2 Longjin Description and Business Overview
6.18.3 Longjin Somatostatin Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Longjin Somatostatin Product Portfolio
6.18.5 Longjin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Somatostatin Industry Chain Analysis
7.2 Somatostatin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Somatostatin Production Mode & Process Analysis
7.4 Somatostatin Sales and Marketing
7.4.1 Somatostatin Sales Channels
7.4.2 Somatostatin Distributors
7.5 Somatostatin Customer Analysis
8 Somatostatin Market Dynamics
8.1 Somatostatin Industry Trends
8.2 Somatostatin Market Drivers
8.3 Somatostatin Market Challenges
8.4 Somatostatin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Somatostatin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Somatostatin Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Somatostatin Market Competitive Situation by Manufacturers in 2024
Table 4. Global Somatostatin Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Somatostatin Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Somatostatin Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Somatostatin Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Somatostatin Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Somatostatin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Somatostatin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Somatostatin, Product Type & Application
Table 12. Global Key Manufacturers of Somatostatin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Somatostatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatostatin as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Somatostatin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Somatostatin Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Somatostatin Sales Market Share by Region (2020-2025)
Table 19. Global Somatostatin Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Somatostatin Sales Market Share by Region (2026-2031)
Table 21. Global Somatostatin Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Somatostatin Revenue Market Share by Region (2020-2025)
Table 23. Global Somatostatin Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Somatostatin Revenue Market Share by Region (2026-2031)
Table 25. North America Somatostatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Somatostatin Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Somatostatin Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Somatostatin Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Somatostatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Somatostatin Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Somatostatin Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Somatostatin Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Somatostatin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Somatostatin Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Somatostatin Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Somatostatin Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Somatostatin Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Somatostatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Somatostatin Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Somatostatin Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Somatostatin Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Somatostatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Somatostatin Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Somatostatin Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Somatostatin Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Somatostatin Sales (K Pcs) by Type (2020-2025)
Table 51. Global Somatostatin Sales (K Pcs) by Type (2026-2031)
Table 52. Global Somatostatin Sales Market Share by Type (2020-2025)
Table 53. Global Somatostatin Sales Market Share by Type (2026-2031)
Table 54. Global Somatostatin Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Somatostatin Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Somatostatin Revenue Market Share by Type (2020-2025)
Table 57. Global Somatostatin Revenue Market Share by Type (2026-2031)
Table 58. Global Somatostatin Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Somatostatin Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Somatostatin Sales (K Pcs) by Application (2020-2025)
Table 61. Global Somatostatin Sales (K Pcs) by Application (2026-2031)
Table 62. Global Somatostatin Sales Market Share by Application (2020-2025)
Table 63. Global Somatostatin Sales Market Share by Application (2026-2031)
Table 64. Global Somatostatin Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Somatostatin Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Somatostatin Revenue Market Share by Application (2020-2025)
Table 67. Global Somatostatin Revenue Market Share by Application (2026-2031)
Table 68. Global Somatostatin Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Somatostatin Price (USD/Pcs) by Application (2026-2031)
Table 70. Merck (Schweiz) AG Company Information
Table 71. Merck (Schweiz) AG Description and Business Overview
Table 72. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Merck (Schweiz) AG Somatostatin Product
Table 74. Merck (Schweiz) AG Recent Developments/Updates
Table 75. SANOFI-AVENTIS FRANCE Company Information
Table 76. SANOFI-AVENTIS FRANCE Description and Business Overview
Table 77. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. SANOFI-AVENTIS FRANCE Somatostatin Product
Table 79. SANOFI-AVENTIS FRANCE Recent Developments/Updates
Table 80. Lyomark Pharma GmbH Company Information
Table 81. Lyomark Pharma GmbH Description and Business Overview
Table 82. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Lyomark Pharma GmbH Somatostatin Product
Table 84. Lyomark Pharma GmbH Recent Developments/Updates
Table 85. ALFA WASSERMANN S.p.A. Company Information
Table 86. ALFA WASSERMANN S.p.A. Description and Business Overview
Table 87. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. ALFA WASSERMANN S.p.A. Somatostatin Product
Table 89. ALFA WASSERMANN S.p.A. Recent Developments/Updates
Table 90. Polypeptide Laboratories, Inc Company Information
Table 91. Polypeptide Laboratories, Inc Description and Business Overview
Table 92. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Polypeptide Laboratories, Inc Somatostatin Product
Table 94. Polypeptide Laboratories, Inc Recent Developments/Updates
Table 95. SAMARTH Company Information
Table 96. SAMARTH Description and Business Overview
Table 97. SAMARTH Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. SAMARTH Somatostatin Product
Table 99. SAMARTH Recent Developments/Updates
Table 100. UBPL Company Information
Table 101. UBPL Description and Business Overview
Table 102. UBPL Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. UBPL Somatostatin Product
Table 104. UBPL Recent Developments/Updates
Table 105. HYBIO Company Information
Table 106. HYBIO Description and Business Overview
Table 107. HYBIO Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. HYBIO Somatostatin Product
Table 109. HYBIO Recent Developments/Updates
Table 110. TianTaiShan Company Information
Table 111. TianTaiShan Description and Business Overview
Table 112. TianTaiShan Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. TianTaiShan Somatostatin Product
Table 114. TianTaiShan Recent Developments/Updates
Table 115. Yangtze River Company Information
Table 116. Yangtze River Description and Business Overview
Table 117. Yangtze River Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Yangtze River Somatostatin Product
Table 119. Yangtze River Recent Developments/Updates
Table 120. Siyao Company Information
Table 121. Siyao Description and Business Overview
Table 122. Siyao Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Siyao Somatostatin Product
Table 124. Siyao Recent Developments/Updates
Table 125. Shuangcheng Company Information
Table 126. Shuangcheng Description and Business Overview
Table 127. Shuangcheng Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Shuangcheng Somatostatin Product
Table 129. Shuangcheng Recent Developments/Updates
Table 130. Hainan Zhonghe Company Information
Table 131. Hainan Zhonghe Description and Business Overview
Table 132. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Hainan Zhonghe Somatostatin Product
Table 134. Hainan Zhonghe Recent Developments/Updates
Table 135. SL PHARM Company Information
Table 136. SL PHARM Description and Business Overview
Table 137. SL PHARM Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. SL PHARM Somatostatin Product
Table 139. SL PHARM Recent Developments/Updates
Table 140. Wuhan Hualong Company Information
Table 141. Wuhan Hualong Description and Business Overview
Table 142. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Wuhan Hualong Somatostatin Product
Table 144. Wuhan Hualong Recent Developments/Updates
Table 145. Qingdao Guoda Company Information
Table 146. Qingdao Guoda Description and Business Overview
Table 147. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Qingdao Guoda Somatostatin Product
Table 149. Qingdao Guoda Recent Developments/Updates
Table 150. Chengdu Shengnuo Company Information
Table 151. Chengdu Shengnuo Description and Business Overview
Table 152. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Chengdu Shengnuo Somatostatin Product
Table 154. Chengdu Shengnuo Recent Developments/Updates
Table 155. Longjin Company Information
Table 156. Longjin Description and Business Overview
Table 157. Longjin Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Longjin Somatostatin Product
Table 159. Longjin Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Somatostatin Distributors List
Table 163. Somatostatin Customers List
Table 164. Somatostatin Market Trends
Table 165. Somatostatin Market Drivers
Table 166. Somatostatin Market Challenges
Table 167. Somatostatin Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Somatostatin
Figure 2. Global Somatostatin Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Somatostatin Market Share by Type: 2024 & 2031
Figure 4. 0.25mg/pcs Product Picture
Figure 5. 0.75mg/pcs Product Picture
Figure 6. 3mg/pcs Product Picture
Figure 7. Global Somatostatin Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Somatostatin Market Share by Application: 2024 & 2031
Figure 9. Hormonal Disorder
Figure 10. Oncology
Figure 11. Metabolic Disorder
Figure 12. Others
Figure 13. Global Somatostatin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Somatostatin Market Size (2020-2031) & (US$ Million)
Figure 15. Global Somatostatin Sales (2020-2031) & (K Pcs)
Figure 16. Global Somatostatin Average Price (USD/Pcs) & (2020-2031)
Figure 17. Somatostatin Report Years Considered
Figure 18. Somatostatin Sales Share by Manufacturers in 2024
Figure 19. Global Somatostatin Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Somatostatin Players: Market Share by Revenue in Somatostatin in 2024
Figure 21. Somatostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Somatostatin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Somatostatin Sales Market Share by Country (2020-2031)
Figure 24. North America Somatostatin Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Somatostatin Sales Market Share by Country (2020-2031)
Figure 28. Europe Somatostatin Revenue Market Share by Country (2020-2031)
Figure 29. Germany Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Somatostatin Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Somatostatin Revenue Market Share by Region (2020-2031)
Figure 36. China Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Somatostatin Sales Market Share by Country (2020-2031)
Figure 46. Latin America Somatostatin Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Somatostatin Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Somatostatin Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Somatostatin by Type (2020-2031)
Figure 56. Global Revenue Market Share of Somatostatin by Type (2020-2031)
Figure 57. Global Somatostatin Price (USD/Pcs) by Type (2020-2031)
Figure 58. Global Sales Market Share of Somatostatin by Application (2020-2031)
Figure 59. Global Revenue Market Share of Somatostatin by Application (2020-2031)
Figure 60. Global Somatostatin Price (USD/Pcs) by Application (2020-2031)
Figure 61. Somatostatin Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Somatostatin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Somatostatin Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Somatostatin Market Competitive Situation by Manufacturers in 2024
Table 4. Global Somatostatin Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Somatostatin Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Somatostatin Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Somatostatin Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Somatostatin Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Somatostatin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Somatostatin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Somatostatin, Product Type & Application
Table 12. Global Key Manufacturers of Somatostatin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Somatostatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatostatin as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Somatostatin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Somatostatin Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Somatostatin Sales Market Share by Region (2020-2025)
Table 19. Global Somatostatin Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Somatostatin Sales Market Share by Region (2026-2031)
Table 21. Global Somatostatin Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Somatostatin Revenue Market Share by Region (2020-2025)
Table 23. Global Somatostatin Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Somatostatin Revenue Market Share by Region (2026-2031)
Table 25. North America Somatostatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Somatostatin Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Somatostatin Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Somatostatin Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Somatostatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Somatostatin Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Somatostatin Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Somatostatin Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Somatostatin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Somatostatin Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Somatostatin Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Somatostatin Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Somatostatin Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Somatostatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Somatostatin Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Somatostatin Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Somatostatin Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Somatostatin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Somatostatin Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Somatostatin Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Somatostatin Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Somatostatin Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Somatostatin Sales (K Pcs) by Type (2020-2025)
Table 51. Global Somatostatin Sales (K Pcs) by Type (2026-2031)
Table 52. Global Somatostatin Sales Market Share by Type (2020-2025)
Table 53. Global Somatostatin Sales Market Share by Type (2026-2031)
Table 54. Global Somatostatin Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Somatostatin Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Somatostatin Revenue Market Share by Type (2020-2025)
Table 57. Global Somatostatin Revenue Market Share by Type (2026-2031)
Table 58. Global Somatostatin Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Somatostatin Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Somatostatin Sales (K Pcs) by Application (2020-2025)
Table 61. Global Somatostatin Sales (K Pcs) by Application (2026-2031)
Table 62. Global Somatostatin Sales Market Share by Application (2020-2025)
Table 63. Global Somatostatin Sales Market Share by Application (2026-2031)
Table 64. Global Somatostatin Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Somatostatin Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Somatostatin Revenue Market Share by Application (2020-2025)
Table 67. Global Somatostatin Revenue Market Share by Application (2026-2031)
Table 68. Global Somatostatin Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Somatostatin Price (USD/Pcs) by Application (2026-2031)
Table 70. Merck (Schweiz) AG Company Information
Table 71. Merck (Schweiz) AG Description and Business Overview
Table 72. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Merck (Schweiz) AG Somatostatin Product
Table 74. Merck (Schweiz) AG Recent Developments/Updates
Table 75. SANOFI-AVENTIS FRANCE Company Information
Table 76. SANOFI-AVENTIS FRANCE Description and Business Overview
Table 77. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. SANOFI-AVENTIS FRANCE Somatostatin Product
Table 79. SANOFI-AVENTIS FRANCE Recent Developments/Updates
Table 80. Lyomark Pharma GmbH Company Information
Table 81. Lyomark Pharma GmbH Description and Business Overview
Table 82. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Lyomark Pharma GmbH Somatostatin Product
Table 84. Lyomark Pharma GmbH Recent Developments/Updates
Table 85. ALFA WASSERMANN S.p.A. Company Information
Table 86. ALFA WASSERMANN S.p.A. Description and Business Overview
Table 87. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. ALFA WASSERMANN S.p.A. Somatostatin Product
Table 89. ALFA WASSERMANN S.p.A. Recent Developments/Updates
Table 90. Polypeptide Laboratories, Inc Company Information
Table 91. Polypeptide Laboratories, Inc Description and Business Overview
Table 92. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Polypeptide Laboratories, Inc Somatostatin Product
Table 94. Polypeptide Laboratories, Inc Recent Developments/Updates
Table 95. SAMARTH Company Information
Table 96. SAMARTH Description and Business Overview
Table 97. SAMARTH Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. SAMARTH Somatostatin Product
Table 99. SAMARTH Recent Developments/Updates
Table 100. UBPL Company Information
Table 101. UBPL Description and Business Overview
Table 102. UBPL Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. UBPL Somatostatin Product
Table 104. UBPL Recent Developments/Updates
Table 105. HYBIO Company Information
Table 106. HYBIO Description and Business Overview
Table 107. HYBIO Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. HYBIO Somatostatin Product
Table 109. HYBIO Recent Developments/Updates
Table 110. TianTaiShan Company Information
Table 111. TianTaiShan Description and Business Overview
Table 112. TianTaiShan Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. TianTaiShan Somatostatin Product
Table 114. TianTaiShan Recent Developments/Updates
Table 115. Yangtze River Company Information
Table 116. Yangtze River Description and Business Overview
Table 117. Yangtze River Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Yangtze River Somatostatin Product
Table 119. Yangtze River Recent Developments/Updates
Table 120. Siyao Company Information
Table 121. Siyao Description and Business Overview
Table 122. Siyao Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Siyao Somatostatin Product
Table 124. Siyao Recent Developments/Updates
Table 125. Shuangcheng Company Information
Table 126. Shuangcheng Description and Business Overview
Table 127. Shuangcheng Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Shuangcheng Somatostatin Product
Table 129. Shuangcheng Recent Developments/Updates
Table 130. Hainan Zhonghe Company Information
Table 131. Hainan Zhonghe Description and Business Overview
Table 132. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Hainan Zhonghe Somatostatin Product
Table 134. Hainan Zhonghe Recent Developments/Updates
Table 135. SL PHARM Company Information
Table 136. SL PHARM Description and Business Overview
Table 137. SL PHARM Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. SL PHARM Somatostatin Product
Table 139. SL PHARM Recent Developments/Updates
Table 140. Wuhan Hualong Company Information
Table 141. Wuhan Hualong Description and Business Overview
Table 142. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Wuhan Hualong Somatostatin Product
Table 144. Wuhan Hualong Recent Developments/Updates
Table 145. Qingdao Guoda Company Information
Table 146. Qingdao Guoda Description and Business Overview
Table 147. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Qingdao Guoda Somatostatin Product
Table 149. Qingdao Guoda Recent Developments/Updates
Table 150. Chengdu Shengnuo Company Information
Table 151. Chengdu Shengnuo Description and Business Overview
Table 152. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Chengdu Shengnuo Somatostatin Product
Table 154. Chengdu Shengnuo Recent Developments/Updates
Table 155. Longjin Company Information
Table 156. Longjin Description and Business Overview
Table 157. Longjin Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Longjin Somatostatin Product
Table 159. Longjin Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Somatostatin Distributors List
Table 163. Somatostatin Customers List
Table 164. Somatostatin Market Trends
Table 165. Somatostatin Market Drivers
Table 166. Somatostatin Market Challenges
Table 167. Somatostatin Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Somatostatin
Figure 2. Global Somatostatin Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Somatostatin Market Share by Type: 2024 & 2031
Figure 4. 0.25mg/pcs Product Picture
Figure 5. 0.75mg/pcs Product Picture
Figure 6. 3mg/pcs Product Picture
Figure 7. Global Somatostatin Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Somatostatin Market Share by Application: 2024 & 2031
Figure 9. Hormonal Disorder
Figure 10. Oncology
Figure 11. Metabolic Disorder
Figure 12. Others
Figure 13. Global Somatostatin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Somatostatin Market Size (2020-2031) & (US$ Million)
Figure 15. Global Somatostatin Sales (2020-2031) & (K Pcs)
Figure 16. Global Somatostatin Average Price (USD/Pcs) & (2020-2031)
Figure 17. Somatostatin Report Years Considered
Figure 18. Somatostatin Sales Share by Manufacturers in 2024
Figure 19. Global Somatostatin Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Somatostatin Players: Market Share by Revenue in Somatostatin in 2024
Figure 21. Somatostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Somatostatin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Somatostatin Sales Market Share by Country (2020-2031)
Figure 24. North America Somatostatin Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Somatostatin Sales Market Share by Country (2020-2031)
Figure 28. Europe Somatostatin Revenue Market Share by Country (2020-2031)
Figure 29. Germany Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Somatostatin Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Somatostatin Revenue Market Share by Region (2020-2031)
Figure 36. China Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Somatostatin Sales Market Share by Country (2020-2031)
Figure 46. Latin America Somatostatin Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Somatostatin Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Somatostatin Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Somatostatin Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Somatostatin by Type (2020-2031)
Figure 56. Global Revenue Market Share of Somatostatin by Type (2020-2031)
Figure 57. Global Somatostatin Price (USD/Pcs) by Type (2020-2031)
Figure 58. Global Sales Market Share of Somatostatin by Application (2020-2031)
Figure 59. Global Revenue Market Share of Somatostatin by Application (2020-2031)
Figure 60. Global Somatostatin Price (USD/Pcs) by Application (2020-2031)
Figure 61. Somatostatin Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232